Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
According to a Danish report, some women using hormonal contraceptives other than birth control pills have an increased risk for serious blood clots.
These alternate hormone-releasing birth control methods include skin patches, implants and vaginal rings. According to the researchers, to reduce the risk, women who use these should consider switching to safer birth control pills.
Nuvaring Blood Clot Risks
Medtronic faces an increasing number of product liability and personal injury lawsuit. Most recently, a Louisiana man, filed a lawsuit alleging that the company’s Infuse bone graft caused unwanted bone growth along his spinal cord, which worsened his back pain following a lumbar fusion.
The plaintiff, Martin Gavin alleges that Medtronic concealed information about the risk of complications from the Medtronic Infuse bone graft.
What is Medtronic Infuse?
According to new medical research, metal-on-metal hip replacements may corrode faster than traditional types of artificial hip implants, such as those made from plastic or ceramic.
Experts speculate that the corrosion may be linked to an increased risk of local tissue reactions that require revision or removal of the artificial hip implant.
Researchers examined corrosion on the heads of metal-on-metal hip implants, and compared it to the corrosion found on metal-on-polyethylene implants, which have a plastic liner between the metal femoral head and metal acetabular cup. This study is published in the Journal of Arthroplasty,
The DePuy Pinnacle MDL that is consolidated in the Northern District of Texas, has had some new orders issued by the court.
Judge James E. Kinkeade, who is overseeing In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation (“MDL No. 2244”), has issued three new orders that will facilitate the discovery phase of the federal DePuy litigation.
Metal on metal hip implants are under fire for premature failure, metallosis, hip infections, elevated cobalt and chromium levels and the need for revision.
What is Infuse?
The Medtronic Infuse bone graft is a genetically engineered liquid protein that helps the body to grow its own bone. It includes a bioengineered protein manufactured by Wyeth, called bone morphogenetic protein (BMP).
Scope of the Infuse Problem
According to attorneys, DePuy ASR hip implants which were recalled by the company in 2010, will start going to trial later this year to help determine liability and damages in more than 6,000 lawsuits.
J&J’s DePuy unit recalled its 93,000 ASR hips worldwide in 2010, including 37,000 in the U.S. According to medical experts, more than 12 percent of the devices failed within five years.
According to the allegations raised in lawsuits, filed in federal and state courts, patients are in pain and immobilized by joint dislocations, infections, bone fractures, and a medical condition known as metallosis.
The Biomet M2a-Magnum hip implant is the latest metal-on-metal hip device to come under scrutiny following reports of a wide range of adverse side effects associated with it.
What is Biomet M2A-Magnum Hip?
The Biomet M2A-Magnum Hip is a metal-on-metal hip replacement system that has been implanted in patients throughout the United States.
A Tennessee man has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage.
According to the complaint, Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects may be irreversible.
The plaintiff alleges that he was prescribed Pradaxa, and after 2 months of use, he suffered a cerebral hemorrhage, as well as other severe personal injuries which are permanent in nature.
According to Bayer AG, the German pharmaceutical giant has shelled out $142 million so far, in settlements of U.S. lawsuits claiming that its Yaz, Yasmin and Ocella line of birth-control pills caused blood clots.
Bayer, said today in its Stockholders’ Newsletter for the first quarter, that it has resolved 651 cases alleging its Yasmin and Yaz contraceptives caused blood clots that can lead to heart attacks, deep vein thrombosis, pulmonary embolism and strokes.
The company said it paid $142 million in the settlements, for an average of about $218,000 a case.
Today, in Dallas, Texas, my home town, the attorneys involved in the multi-district consolidated federal DePuy Pinnacle litigation, met with Judge Ed Kinkeade, who is overseeing the MDL Court.
The topics that were discussed included the recent Case Management Order that is to provide a schedule for proceeding with the Pinnacle metal on metal hip lawsuits.
From my vantage point in the “peanut gallery,” I counted 6 attorneys from the defense and about 35 plaintiff attorneys and each side made a short presentation on the status of the lawsuits at this time.
Dallas Fort Worth Injury Lawyer Blog